NCT05445583 Asthma and Technology in Emerging African American Adults
| NCT ID | NCT05445583 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Asthma |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2023-08-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the ATHENA Project is to test a mobile health intervention to help African American young adults better manage their asthma. The program has four components: 1) a web-based, mobile asthma program delivered to participants' mobile device, 2) meetings with an asthma nurse via video conference, 3) text messaging, and 4) physical activity tracking. Participants will be randomly assigned to one or more of these components to better meet the needs of young adults with asthma.
Eligibility Criteria
Inclusion Criteria: * African American, 18-30 years of age, uncontrolled asthma (defined by a score of less than 19 on the ACT), own or have access to a cell phone for the duration of the study, have a primary care physician (PCP) Exclusion Criteria: * Significant cardiopulmonary disease (including chronic obstructive pulmonary disease), a greater than 20 pack per year smoking history, developmental delay or mental illness such that participation in the program would not be possible, pregnancy
Contact & Investigator
Alan Baptist, MD.
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT05445583 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05445583 currently recruiting?
Yes, NCT05445583 is actively recruiting participants. Contact the research team at abaptist@med.umich.edu for enrollment information.
Where is the NCT05445583 trial being conducted?
This trial is being conducted at Tallahassee, United States, Ann Arbor, United States, Detroit, United States.
Who is sponsoring the NCT05445583 clinical trial?
NCT05445583 is sponsored by University of Michigan. The principal investigator is Alan Baptist, MD. at University of Michigan. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.